P18-08. Characterization of CD34+ derived dendritic cells generated <it>in vitro </it>and transfected with HIV gene as potential therapeutic vaccine in macaque by Le Grand R, Vanham G, Banchereau J, Van Gulck E, Zurawski G, Romain G, Martinon F

P17-16. Anti-Langerin-HIV Gag p24 fusion protein targeting Langerhans cells as a new anti-HIV vaccine strategy by Le Grand R, Banchereau J, Delache B, Brochard P, Zurawsky G, Flamar A, Culina S, Martinon F

P11-15. Induction of a mucosal immune response to HIV after systemic immunization with poly(lactic acid) nanoparticles formulated with gag antigen and polyI:C by Delair T, Luciani E, Calamel A, Munier S, Martinon F, Weber C, Primard C, Le Grand R, Verrier B

P19-26. Directing macaque immune responses with an anti-dendritic cell HIV Gag p24 fusion protein vaccine by Martinon F, Dereuddre-Bosquet N, Méderlé-Mangeot I, Flamar A, Zurawski S, Verrier B, Oh S, Zurawski G, Banchereau J, Le Grand R

OA05-03. Efficacy study of a T-cell-based DNA vaccine delivered by intradermal electrotransfer in macaques by Le Grand R, Ustav M, Stanescu I, Männik A, Kaldma K, Sikut R, Méderlé-Mangeot I, Baron M, Dereuddre-Bosquet N, Martinon F

P17-11. HIV DNA vaccine delivery in association with electroporation in the skin of nonhuman primates by Le Grand R, Ustav M, Stanescu I, Kivisild T, Toots U, Männik A, Sikut R, Adojaan M, Kaldma K, Mannioui A, Culina S, Martinon F

P17-10. A new AuxoGTU-HIV B DNA vaccine induce very long lasting HIV specific T cells response which is efficiently boosted with HIV LAI lipopeptides by Le-Grand R, Lévy Y, Derreudre-Bosquet N, Stanescu I, Ustav M, Sikut R, Kaldma K, Langlois S, Corneau A, Sylla N, Mangeot-Méderlé I, Martinon F

AIM2 inflammasome is activated by pharmacological disruption of nuclear envelope integrity by Di Micco, A, Frera, G, Lugrin, J, Jamilloux, Y, Hsu, E, Tardivel, A, De Gassart, A, Zaffalon, L, Bujisic, B, Siegert, S, Quadroni, M, Broz, P, Henry, T, Hrycyna, C, Martinon, F